Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Dec 2018 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 21.33M | 19.14M | 15.49M | 9.64M | 3.85M | 0.00 |
Gross Profit | 17.77M | 14.48M | 11.82M | 6.92M | 3.74M | 0.00 |
EBITDA | -5.98M | -4.96M | -5.51M | -7.54M | -10.11M | 778.25K |
Net Income | -8.29M | -6.64M | -7.08M | -7.81M | -9.90M | -18.09K |
Balance Sheet | ||||||
Total Assets | 6.66M | 11.19M | 6.45M | 10.65M | 406.78K | 84.20K |
Cash, Cash Equivalents and Short-Term Investments | 365.22K | 3.07M | 1.46M | 7.69M | 406.78K | 84.20K |
Total Debt | 13.87M | 12.39M | 4.55M | 713.02K | 713.02K | 0.00 |
Total Liabilities | 18.70M | 17.13M | 8.32M | 2.13M | 17.18K | 8.00K |
Stockholders Equity | -12.04M | -5.95M | -1.87M | 8.53M | 389.59K | 76.20K |
Cash Flow | ||||||
Free Cash Flow | -5.13M | -10.20M | -4.59M | -1.31M | -566.27K | -33.69K |
Operating Cash Flow | -6.94M | -6.11M | -2.00M | -809.16K | -66.53K | -33.69K |
Investing Cash Flow | -2.05M | -4.09M | -2.69M | -252.89K | -252.89K | 0.00 |
Financing Cash Flow | 4.01M | 11.91M | 5.28M | 8.68M | 389.11K | 50.00K |
Jack Nathan Health reported a 16% year-to-date revenue growth in its Q3 fiscal 2025 results, driven primarily by its expanding operations in Mexico. The company has completed the sale of its Canadian operations and is focusing on growing its Mexican clinics and exploring opportunities in the MedSpa sector.
Jack Nathan Health has completed the sale of its Canadian business to WELL Health Technologies for Cdn$5 million, eliminating over Cdn$15 million in debt and streamlining its capital structure. The company will focus on its profitable Mexican operations, including clinics in Walmart locations, while securing future growth through a cash infusion from the asset sale.